NVNO · NASDAQ
enVVeno Medical (NVNO) Stock Price & Fundamentals
enVVeno Medical (NVNO) closed at $721.12 on Oct 9, 2026, down 0.72% from the previous close of $726.36.
Share price, past year
1Y +39.17%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $721.12 |
| Sep 30, 2026 | $723.12 |
| Aug 31, 2026 | $714.90 |
| Jul 31, 2026 | $765.26 |
| Jun 30, 2026 | $756.85 |
| May 29, 2026 | $695.67 |
| Apr 30, 2026 | $644.28 |
| Mar 31, 2026 | $643.12 |
| Feb 27, 2026 | $606.71 |
| Jan 30, 2026 | $584.97 |
| Dec 31, 2025 | $558.98 |
| Nov 28, 2025 | $556.44 |
| Oct 31, 2025 | $538.83 |
Key statistics
- Market cap
- $485.31M
- P/E (TTM)
- —
- EPS (TTM)
- −$25.05
- Revenue (TTM)
- —
- Net income (TTM)
- −$15.72M
- Shares outstanding
- 673K
- Dividend yield
- —
- 52-week range
- $518.17 – $775.56
enVVeno Medical's market cap is $485.31M, based on a share price of $721.12 and 673K shares outstanding as of Jun 30, 2026.
Financials
enVVeno Medical reported revenue of $31.24K for fiscal 2019, down 83.25% from fiscal 2018.
enVVeno Medical reported a net loss of $19.47M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2019ended Dec 31, 2019 | $31.24K | −83.3% | −$7.63M | −24,406.7% | −$12.10 | −$6.26M |
| FY2018ended Dec 31, 2018 | $186.55K | −55.8% | −$13.04M | −6,991.5% | −$1.75 | −$6.37M |
| FY2017ended Dec 31, 2017 | $422.11K | — | −$7.79M | −1,845.8% | −$1.35 | −$4.21M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2019ended Mar 31, 2019 | $31.24K | — | — |
| Q4 FY2018ended Dec 31, 2018 | $30.46K | — | — |
| Q3 FY2018ended Sep 30, 2018 | $41.66K | — | — |
| Q2 FY2018ended Jun 30, 2018 | $83.36K | — | — |
| Q1 FY2018ended Mar 31, 2018 | $31.07K | — | — |
| Q3 FY2017ended Sep 30, 2017 | $27.88K | — | — |
| Q2 FY2017ended Jun 30, 2017 | $38.80K | — | — |
Company profile
- Name
- enVVeno Medical Corp
- Ticker
- NVNO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 70 Doppler, Irvine, CA 92618
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001661053
Recent SEC filings
- Jul 30, 2026
- Jul 14, 2026
- May 6, 2026
- Apr 29, 2026
- Mar 26, 2026
- Feb 4, 2026
- Jan 20, 2026
- Dec 12, 2025
Frequently asked questions
What is enVVeno Medical's stock price?
enVVeno Medical (NVNO) closed at $721.12 on Oct 9, 2026, down 0.72% from the previous close of $726.36.
What is enVVeno Medical's market cap?
enVVeno Medical's market cap is $485.31M, based on a share price of $721.12 and 673K shares outstanding as of Jun 30, 2026.
How much revenue does enVVeno Medical make?
enVVeno Medical reported revenue of $31.24K for fiscal 2019, down 83.25% from fiscal 2018.
Does enVVeno Medical pay a dividend?
enVVeno Medical's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from enVVeno Medical Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures